Relmada Therapeutics Inc. – Transcripts

NASDAQ: RLMD
Share price (10/2/26): $3.60
Market cap (10/2/26): $384 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Earnings Revised 08/23/26 Relmada Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 08/06/26

Earnings Revised 06/03/26 Relmada Therapeutics, Inc., Q1 2026 Earnings Call, May 12, 2026 05/12/26

Earnings Revised 03/19/26 Relmada Therapeutics, Inc., Q4 2025 Earnings Call, Mar 19, 2026 03/19/26

CY 2025

Earnings Revised 11/13/25 Relmada Therapeutics, Inc., Q3 2025 Earnings Call, Nov 13, 2025 11/13/25

Earnings Revised 08/07/25 Relmada Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 08/07/25

Earnings Revised 05/21/25 Relmada Therapeutics, Inc., Q1 2025 Earnings Call, May 12, 2025 05/12/25

Other Revised 05/01/25 Relmada Therapeutics, Inc. - Special Call 04/28/25

Earnings Revised 04/11/25 Relmada Therapeutics, Inc., Q4 2024 Earnings Call, Mar 27, 2025 03/27/25

CY 2024

Earnings Revised 11/07/24 Relmada Therapeutics, Inc., Q3 2024 Earnings Call, Nov 07, 2024 11/07/24

Earnings Revised 09/02/24 Relmada Therapeutics, Inc., Q2 2024 Earnings Call, Aug 07, 2024 08/07/24

Other Revised 07/22/24 Relmada Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 11:20 AM 06/12/24

Earnings Revised 05/08/24 Relmada Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 05/08/24

Earnings Revised 04/17/24 Relmada Therapeutics, Inc., 2023 Earnings Call, Mar 19, 2024 03/19/24

CY 2023

Earnings Revised 11/08/23 Relmada Therapeutics, Inc., Q3 2023 Earnings Call, Nov 08, 2023 11/08/23

Earnings Revised 08/08/23 Relmada Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 08/08/23

Other Revised 06/14/23 Relmada Therapeutics, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 03:20 PM 06/14/23

Earnings Revised 07/13/23 Relmada Therapeutics, Inc., Q1 2023 Earnings Call, May 11, 2023 05/11/23

Earnings Revised 03/23/23 Relmada Therapeutics, Inc., Q4 2022 Earnings Call, Mar 23, 2023 03/23/23

CY 2022

Other Revised 12/07/22 Relmada Therapeutics, Inc. - Special Call 12/07/22

Earnings Revised 11/10/22 Relmada Therapeutics, Inc., Q3 2022 Earnings Call, Nov 10, 2022 11/10/22

Earnings Revised 08/11/22 Relmada Therapeutics, Inc., Q2 2022 Earnings Call, Aug 11, 2022 08/11/22

Other Revised 06/14/22 Relmada Therapeutics, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-14-2022 10:40 AM 06/14/22

Earnings Revised 05/05/22 Relmada Therapeutics, Inc., Q1 2022 Earnings Call, May 05, 2022 05/05/22

Earnings Revised 03/23/22 Relmada Therapeutics, Inc., Q4 2021 Earnings Call, Mar 23, 2022 03/23/22

Other Revised 02/23/22 Relmada Therapeutics, Inc. - Special Call 02/23/22

CY 2021

Earnings Revised 11/11/21 Relmada Therapeutics, Inc., Q3 2021 Earnings Call, Nov 11, 2021 11/11/21

Other Revised 09/10/21 Relmada Therapeutics, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-10-2021 12:30 PM 09/10/21

Earnings Revised 08/10/21 Relmada Therapeutics, Inc., Q2 2021 Earnings Call, Aug 10, 2021 08/10/21

Other Revised 07/27/21 Relmada Therapeutics, Inc. - Special Call 07/27/21

Earnings Revised 05/12/21 Relmada Therapeutics, Inc., Q1 2021 Earnings Call, May 12, 2021 05/12/21

Earnings Revised 03/23/21 Relmada Therapeutics, Inc., Q4 2020 Earnings Call, Mar 23, 2021 03/23/21